BioProcess Insider Interview with Marc Hummersone

Highlighting the rapid proliferation of cell and gene therapies (CGTs), Hummersone described how his company seeks to support downstream processing for emerging therapies.

Previous Video
BioProcess Insider Interview with Steve Burton
BioProcess Insider Interview with Steve Burton

Having spent 30 years in the biopharmaceutical industry, Burton has witnessed monumental shifts in biomanuf...

Next Video
Reliable Solutions for Downstream Processing Contaminant Removal - Dr. Claire Dacombe
Reliable Solutions for Downstream Processing Contaminant Removal - Dr. Claire Dacombe